Atrás
Precio MoonLake Immunotherapeutics (MLTX)
Gráfico del Precio de Acciones MLTX
MLTX Ganando
MoonLake Immunotherapeutics
$16.33
-2.56%
$-0.43
Al cierre: Jan 20, 16:00:00 GMT-5
$16.27
-0.36%
$-0.05
Mercado Posterior: Jan 20, 16:59:54 GMT-5
Estadísticas clave
Cierre Anterior
$16.76
Precio de apertura
$16.5
Rango del día
$16.16 - $17
Rango de 52 semanas
$5.95 - $62.75
Volumen
2.1M
Volumen promedio
4.5M
EPS (TTM)
-3.33
Rendimiento de dividendos
--
Cap. de mercado
$1.1B
¿Qué es MLTX?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 100 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved